Slimming Drugs UK: Understanding Prescription Weight Management Medicines

• Explains what prescription slimming drugs actually are
• Covers injectable and oral weight-management medicines
• Separates regulated medicines from unverified slimming products
• Explains why medicine choice depends on clinical assessment

What exactly does the term “slimming drugs” mean? It is a phrase you will often see in searches, but it does not describe one particular type of medicine.

In healthcare, the more accurate term is prescription weight-management medicine. These medicines have specific authorised uses, eligibility requirements and prescribing safeguards. They are not ordinary slimming products that anyone can buy without assessment.

NICE recommends considering weight-management medicines for some adults after dietary, physical activity and behavioural approaches have been started and evaluated. The medicines are used alongside a reduced-calorie diet and increased physical activity, rather than as a replacement for the wider approach to weight management. The exact eligibility criteria depend on the medicine and the individual's circumstances.

Key things to know

• “Slimming drug” is an informal search term rather than a specific medicine category.
• Several types of prescription medicine can be used for weight management.
• Some medicines act on hormone pathways involved in appetite and feelings of fullness.
• Weight-management medicines can be injectable or oral.
• Not every medicine associated with weight change is authorised for weight management.
• Prescription treatment should not be selected based on popularity or online reviews alone.
• Suitability depends on an individual clinical assessment.
• Medicines are used alongside wider weight-management measures.
• Unregulated weight-loss products can carry significant risks.
• Individual response to treatment can vary.

What Are Slimming Drugs?

“ Slimming drugs” is a broad term people use for medicines associated with weight loss. The problem is that it can make very different products sound as though they are all the same.

A prescription weight-management medicine has a defined authorised use and is prescribed when a healthcare professional considers it appropriate. Some medicines affect appetite-related hormone pathways, while others work in different ways.

A tablet or injection being marketed for slimming does not automatically make it an authorised medicine. The exact product, active ingredient, authorised use and supply route all matter.

What Are Prescription Slimming Drugs?

Prescription slimming drugs are more accurately described as prescription weight-management medicines.

In the UK, prescription medicines used for weight management require an appropriate prescribing decision. NICE currently includes tirzepatide, semaglutide, liraglutide and orlistat among medicine options for adults with overweight or obesity, with different criteria and treatment settings for each medicine.

Eligibility can involve BMI and weight-related health conditions, but there is no single BMI rule that applies to every medicine. The medicine being considered and the person's wider health circumstances both matter.

This is why two people with similar weights may not necessarily be offered the same treatment.

How Do Slimming Drugs Work?

There is no single way that all prescription weight-management medicines work.

Some newer medicines act on hormone pathways involved in appetite and feelings of fullness. GLP-1 receptor agonists, for example, mimic the action of a natural hormone released after eating. Other medicines work through different mechanisms.

The active ingredient therefore matters. It determines how the medicine works, what it is authorised to treat, how it should be taken and what safety information applies.

What Are GLP-1 Weight-Management Medicines?

GLP-1 receptor agonists are one group of prescription medicines used for certain medical conditions, including weight management where the specific medicine is authorised for that purpose.

They mimic the action of GLP-1, a natural hormone released after eating, and can help people feel fuller. Some newer medicines, such as tirzepatide, act on both GLP-1 and another hormone pathway called GIP.

You may see GLP-1 medicines described online as weight-loss injections or similar terms. However, not every GLP-1 medicine is authorised for weight management, and medicines within the same broad group are not automatically interchangeable.

Are All Slimming Drugs Injections?

No. The UK now has both injectable and oral prescription weight-management medicines.

The MHRA authorised semaglutide (Wegovy) as the UK's first GLP-1 receptor agonist tablet specifically for weight loss and weight management in June 2026. Orforglipron (Foundayo) was also authorised as a daily tablet for weight management and type 2 diabetes in August 2026.

This gives eligible patients and prescribers more treatment formats to consider. It does not mean that tablets are automatically more suitable than injections, or that one format will produce the same result for everyone.

Are Weight-Loss Tablets the Same as Slimming Drugs?

The terms can overlap in everyday searches, but not every slimming tablet is a regulated prescription medicine.

A tablet can be an authorised weight-management medicine when it has the appropriate UK authorisation and is prescribed for someone who meets the relevant criteria. On the other hand, a product sold online as a “slimming pill” may be an unlicensed or otherwise unregulated product.

The MHRA warns against buying weight-loss medicines from unregulated websites or social media. Products supplied illegally may be fake, contaminated, incorrectly dosed or contain ingredients that are not listed on the packaging.

Are Prescription Slimming Drugs Available Without a Prescription?

Prescription weight-management medicines should not be obtained by bypassing normal prescribing requirements.

The MHRA states that GLP-1 medicines and other prescription treatments for weight management should only be supplied following an appropriate clinical assessment. It also advises people not to buy prescription-only medicines without a prescription.

A legitimate treatment pathway therefore starts with clinical assessment rather than unrestricted purchase.

Who Can Be Considered for Prescription Weight-Management Medicine?

Wanting to lose weight does not automatically mean that prescription treatment is appropriate.

The prescriber may consider:

• BMI and weight-related health risks;
• relevant medical history;
• current medicines;
• previous weight-management approaches;
• the authorised criteria for the medicine being considered; and
• factors that could affect safe treatment.

For example, NICE has different eligibility criteria for medicines such as tirzepatide, semaglutide, liraglutide and orlistat. Some recommendations also use lower BMI thresholds for people from certain ethnic backgrounds because weight-related health risks can occur at lower BMI levels.

The exact criteria therefore need to be checked for the medicine being considered rather than applying one general rule to every treatment.

Are Slimming Drugs a Replacement for Diet and Physical Activity?

Medication is only one part of weight management.

NICE states that weight-management medicines should be used alongside a reduced-calorie diet and increased physical activity. Behavioural and lifestyle support also form part of the wider approach.

That does not mean someone has to follow a perfect diet or exercise routine. The aim is to build practical changes that can fit into everyday life while treatment is reviewed.

For some people, this may include changing portion sizes, choosing more nutrient-rich foods, increasing everyday movement or finding ways to make physical activity easier to maintain.

Can You Choose a Slimming Drug Based on Expected Weight Loss?

It is understandable to look at weight-loss figures when comparing medicines, but a result from someone else's treatment should not be treated as a personal prediction.

Clinical results can differ because studies involve different medicines, doses, treatment periods and groups of people. Individual response can also vary.

The more useful question is whether a particular medicine is clinically appropriate for you, rather than which medicine appears to produce the largest number in an online comparison.

Can a Medicine Used for Another Condition Automatically Be Treated as a Slimming Drug?

No. A medicine being linked with weight change does not automatically make it an authorised weight-management treatment.

The exact medicinal product and authorised indication matter. For example, the MHRA lists different authorised uses for semaglutide products such as Wegovy, Ozempic and Rybelsus. Tirzepatide, sold as Mounjaro, has also been authorised for both diabetes and weight-management uses, depending on the indication.

This is why the active ingredient alone is not enough to determine whether a particular medicine is suitable for weight management.

What Is New With Prescription Slimming Drugs in 2026?

One of the biggest changes this year is the arrival of oral GLP-1 treatment for weight management in the UK.

On 11 June 2026, the MHRA authorised semaglutide (Wegovy) as the UK's first GLP-1 receptor agonist tablet specifically for weight loss and weight management. In August 2026, orforglipron (Foundayo) was also authorised for weight management and type 2 diabetes.

This expands the available treatment formats. It does not mean that newer treatment is automatically more suitable than an existing option.

Why Should New Slimming Drugs Be Treated Carefully?

New medicines can attract a lot of attention online, especially before they are widely available.

In June 2026, the MHRA, ASA and GPhC warned businesses about promoting newly authorised prescription-only medicines and unlicensed weight-management products. The MHRA has also taken action where public advertising was likely to encourage people to request prescription-only weight-loss medicines.

For someone considering treatment, the practical takeaway is simple: check whether a medicine is authorised in the UK and whether it has been prescribed following an appropriate clinical assessment.

Can Prescription Slimming Drugs Be Obtained Online?

An online healthcare service can provide a convenient way to have a clinical consultation where remote prescribing is appropriate.

However, an online consultation should not mean automatic approval. A prescriber still needs enough information to decide whether treatment is appropriate.

A legitimate pathway may look like this:

clinical assessment → prescriber review → treatment decision → prescription where appropriate → registered pharmacy dispensing

The MHRA advises people to obtain weight-management medicines from registered pharmacies and to avoid illegal online sellers.

You can also read more about weight loss treatments and how prescription treatment may form part of a wider weight-management plan.

Why Is Clinical Assessment Important?

Clinical assessment is not simply a formality before getting medicine. It helps establish whether the treatment is appropriate in the first place.

A healthcare professional may need to consider your BMI, health conditions, current medicines, previous treatment and other factors that could affect the choice of medicine.

This is especially important for prescription treatments because the same medicine may be appropriate for one person but unsuitable for another.

How Do You Compare Different Types of Prescription Slimming Drugs?

Comparing medicines only by how much weight people report losing can leave out some important information.

A more useful comparison looks at:

NICE's current guidance includes different medicine options, routes and eligibility requirements, so there is no single set of criteria for every prescription weight-management medicine.

Are Injectable Slimming Drugs More Effective Than Tablets?

The injection or tablet format alone does not tell you whether a medicine is suitable or what result an individual will experience.

Different medicines have different active ingredients, mechanisms, doses, authorised uses and clinical evidence. Oral semaglutide and injectable semaglutide, for example, are different formulations with their own product information.

The UK now has authorised oral options as well as injectable treatments, giving eligible patients more formats to discuss with their prescriber.

Are Oral Slimming Drugs Easier to Use?

For some people, taking a tablet may feel more convenient than using an injection. Others may prefer the routine of an injectable medicine.

There are practical differences in how medicines are taken. Some oral treatments have specific instructions about when and how they should be taken, while injectable medicines have their own administration and storage requirements.

Convenience is therefore worth discussing with a healthcare professional, but it should not replace clinical suitability.

How Long Are Prescription Slimming Drugs Used?

There is no single treatment length that applies to every weight-management medicine.

Treatment duration can depend on the exact medicine, response, side effects, continued eligibility and product-specific guidance. NICE also provides medicine-specific recommendations for reviewing treatment and deciding whether it should continue.

A prescription should therefore not be treated as automatic approval to continue a medicine indefinitely. Ongoing review remains important.

What Happens During a Weight-Management Medicine Review?

A review is an opportunity to look at how treatment is going and whether anything has changed.

Depending on the medicine, a healthcare professional may discuss:

• changes in weight and other relevant measurements;
• side effects and tolerability;
• current medicines;
• changes in health;
• how consistently the medicine is being taken;
• dietary and physical activity support;
• practical difficulties with treatment; and
• whether continuing treatment remains appropriate.

The exact review process varies between medicines. NICE includes ongoing monitoring and review within its recommendations for weight-management medicines.

What if a Slimming Drug Does Not Produce the Expected Result?

It can be disappointing when progress is slower than expected. However, changing the dose or medicine yourself is not the answer.

Individual response varies. A review can look at how the medicine is being used, whether side effects are affecting treatment, whether wider lifestyle support is still appropriate and whether the current treatment remains suitable.

If a medicine is not producing the expected response, speak to the prescriber rather than increasing the dose, combining medicines or switching treatment without advice.

Can You Switch Between Prescription Slimming Drugs?

Sometimes a treatment change may be considered, but it should not be planned independently.

Different medicines can have different mechanisms, doses, authorised uses and safety considerations. The MHRA specifically advises people to speak with a healthcare professional before switching between GLP-1 medicines.

If you are considering a change because of side effects, convenience, cost or treatment response, discuss the reason with your prescriber first.

Can You Combine Different Slimming Drugs?

Do not combine prescription weight-management medicines unless this has been specifically advised by an appropriately qualified healthcare professional.

Using more than one medicine does not automatically mean you will lose more weight and may introduce additional risks or interactions.

Online advice about combining medicines should not replace the prescribing information for the treatments involved.

Can Slimming Drugs Target Stomach Fat?

There is no prescription slimming medicine that should be described as selectively removing fat from the stomach.

Overall weight reduction may be accompanied by changes in waist circumference and body composition, but the pattern of change varies between people.

The location where an injectable medicine is administered does not change this. An injection into the abdomen does not mean the medicine specifically targets abdominal fat.

Do Prescription Slimming Drugs Guarantee Long-Term Weight Control?

No. Prescription medicine cannot guarantee permanent weight control.

Weight management is affected by many factors, including eating patterns, physical activity, behaviour, health conditions and individual circumstances. Medicine may form part of treatment, but it does not remove the need to consider these wider factors.

Long-term treatment decisions should be reviewed with a healthcare professional rather than based on the assumption that previous weight loss will automatically remain unchanged.

What Happens if Prescription Weight-Management Medicine Is Stopped?

What happens after treatment stops can vary between people and medicines.

Some people may find it difficult to maintain previous changes after stopping treatment, particularly if appetite or previous eating patterns return. This does not mean that weight regain is inevitable, but it is one reason why the wider weight-management plan matters.

If you are thinking about stopping treatment, discuss it with your prescriber so that the decision can be considered alongside your overall health and weight-management goals.

Are Cheap Slimming Drugs Online Safe?

Price alone cannot tell you whether a medicine is genuine or safe.

The MHRA has warned about weight-loss medicines sold through illegal or unregulated online sources. These products may be fake, contaminated, incorrectly dosed or contain ingredients that are not listed on the packaging.

If you are comparing costs, check the prescribing and pharmacy pathway first. A very low price should not be a reason to bypass normal medicine safeguards.

How Can You Check an Online Slimming Drug Service?

A professional-looking website is not enough to show that a service is supplying prescription medicine appropriately.

Useful checks include:

• whether a proper clinical assessment is carried out;
• who is responsible for prescribing;
• which pharmacy will dispense the medicine;
• whether the pharmacy can be verified;
• whether clear information about the medicine is provided;
• how the medicine will be supplied; and
• whether support is available if you have questions or concerns.

The MHRA advises people in Great Britain to check that pharmacies are registered with the General Pharmaceutical Council and to avoid medicines sold through unregulated sources.

Should an Online Consultation Guarantee a Prescription?

No. A genuine clinical consultation needs to leave room for the prescriber to decide that a medicine is not suitable.

A prescriber may also need more information before making a decision. This is an important part of safe prescribing, whether the consultation takes place online, by telephone or face to face.

A service that promises approval before an assessment has taken place should be treated with caution.

What Should You Check When Prescription Slimming Drugs Arrive?

A few simple checks can help you spot an unexpected problem before using your medicine.

Check:

• the medicine name;
• the formulation;
• the dispensing label;
• the packaging;
• the expiry date;
• the patient information leaflet; and
• the storage instructions.

The medicine should match the prescription and information supplied by the pharmacy. If something looks different or the packaging appears damaged, contact the dispensing pharmacy before using it.

Why Does the Patient Information Leaflet Matter?

The patient information leaflet is written for the exact medicine you have been supplied.

It explains how the medicine should be used and includes important information about side effects, warnings, interactions and when to seek medical advice.

This matters because two medicines used for weight management can have different instructions and safety information. General information about “slimming drugs” cannot replace the leaflet for your specific medicine.

Should You Buy Unlicensed Products Marketed as Slimming Drugs?

An unlicensed product marketed as a new or powerful slimming treatment should not be treated as an established medicine.

The MHRA has warned about businesses promoting unlicensed weight-management products and products that have not received UK authorisation.

The regulator has also reported seizures of unlicensed weight-loss medicines, showing why the source and regulatory status of a product matter.

If the identity, origin, ingredients or regulatory status of a product are unclear, it should not be treated as equivalent to a prescribed and regulated medicine.

Can Suspected Reactions to Slimming Drugs Be Reported?

Yes. Suspected side effects from medicines can be reported through the MHRA Yellow Card scheme.

Common side effects of some GLP-1 medicines include gastrointestinal symptoms such as nausea, vomiting, diarrhoea and constipation. The exact side effects and their frequency depend on the medicine.

More serious reactions can also occur. The MHRA has strengthened warnings around acute pancreatitis and has updated information about the very rare eye condition non-arteritic anterior ischaemic optic neuropathy, or NAION, associated with semaglutide.

If you develop new or concerning symptoms, seek appropriate medical advice rather than relying only on general information online.

How Do Prescription Slimming Drugs Fit Into a Weight-Loss Plan?

Prescription medicine is one possible part of a wider weight-management plan.

A structured approach may include:

clinical assessment → appropriate treatment decision → dietary support → physical activity → behavioural strategies → monitoring → ongoing review

Not everyone needs prescription medicine. For some people, lifestyle support may be the main approach. Others may be assessed for medicine or specialist weight-management support where appropriate.

The important point is that treatment should be matched to the person's circumstances rather than treated as a one-size-fits-all solution.

What Is the Main Difference Between Slimming Products and Prescription Slimming Drugs?

The main difference is their regulatory and clinical status.

A prescription weight-management medicine has an authorised medical use and is supplied following an appropriate prescribing decision. A product described as “slimming”, “fat burning” or “appetite suppressing” does not automatically have the same status.

Marketing language is therefore not a substitute for checking whether a medicine is authorised and appropriately prescribed.

What Should You Remember About Slimming Drugs in the UK?

“Slimming drugs” is a broad search term, not one specific type of medicine.

The more useful question is: What medicine is being offered, what is it authorised for, and is it appropriate for the person taking it?

The UK now has several prescription weight-management medicines, including injectable and oral options. NICE lists tirzepatide, semaglutide, liraglutide and orlistat for use in specific circumstances, while the MHRA regulates the authorised medicines and their permitted uses.

The safest way to approach prescription treatment is to start with clinical assessment, use an authorised medicine where appropriate, obtain it through a legitimate pharmacy and continue with the recommended monitoring and wider weight-management support.

Medical Disclaimer

Prescription weight-management medicines have specific authorised uses and eligibility requirements. Treatment suitability depends on an individual clinical assessment, and response can vary between people.

This guide provides general information about slimming drugs, prescription weight-management medicines and weight-loss treatment in the UK. It does not provide personalised prescribing, dosing, switching or administration instructions and does not replace advice from a qualified healthcare professional.